Buenavista Equity Partners (via Evidenze) Acquires Chrestos Concept GmbH & Co. KG
November 22, 2024
Buenavista Equity Partners has acquired German CRO Chrestos Concept GmbH & Co. KG through its healthcare platform Evidenze Group Europe. The add-on expands Evidenze's capabilities in clinical trial design, biostatistics and data science and strengthens its presence in Germany as part of a buy-and-build strategy.
- Buyers
- Buenavista Equity Partners, Evidenze Group Europe (Evidenze)
- Targets
- Chrestos Concept GmbH & Co. KG
- Platforms
- Evidenze Group Europe (Evidenze)
- Industry
- Healthcare Services
- Location
- North Rhine-Westphalia, Germany
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
CorEvitas Acquires Vestrum Health
July 22, 2021
Data & Analytics
CorEvitas, a provider of curated real-world evidence and a portfolio company of Audax Private Equity, has added Vestrum Health to its organization. The acquisition brings Vestrum’s retina-focused EHR data analytics and real-world evidence capabilities into CorEvitas’ registry and analytics platform to expand specialty EHR data and RWE services for retina practices and biopharmaceutical customers.
-
EQT, Silver Lake and Nestlé Expand Partnership with €3.5bn Investment in IVC Evidensia
February 9, 2021
Veterinary
IVC Evidensia has secured an aggregated new investment of €3.5 billion that values the company at an enterprise value of approximately €12.3 billion. The expanded partnership includes a substantial reinvestment by EQT Private Equity, a new minority investment from Silver Lake, and an increased minority stake from Nestlé Purina PetCare EMENA to support digitalisation and further growth across IVC's network of clinics.
-
United BioSource (UBC) Acquires Evidinno Outcomes Research
January 5, 2026
Healthcare Services
United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.
-
Everest Clinical Research Acquires Brightech International
December 2, 2022
Healthcare Services
Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.
-
Entrust Acquires Evidos
June 8, 2022
Cloud & SaaS
Entrust has acquired Netherlands-based Evidos, a cloud-based electronic signature and identity verification provider. The acquisition brings Evidos' ~35 employees, European customer base and e-signature technology into Entrust to expand its digital signing and ID verification capabilities globally; terms were not disclosed.
-
Everest Clinical Research (Arlington) Acquires August Research
November 7, 2023
Healthcare Services
Everest Clinical Research, a portfolio company of Arlington Capital Partners, has acquired European contract research organization August Research. The deal expands Everest's European footprint and clinical trial (CTS) and pharmacovigilance (PV) capabilities across 14 countries; August's founders will remain with the business. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.